ADENOCARCINOMA

This study tests a treatment that uses your own immune cells taken from your tumor, grown in a lab, and given back to you to fight advanced non-small cell lung cancer. The goal is to see if these cells can shrink tumors and if the treatment is safe. Participants must be 18-72 and…

This early-phase study tests a powerful mix of five chemotherapy drugs for people with advanced cancers of the pancreas, stomach, bile ducts, or gallbladder that have not been treated yet. The researchers use a genetic test to adjust the dose of one drug (irinotecan) based on how…

This study looks at whether surgically removing para-aortic lymph nodes before standard chemoradiation can help people with stage IIIC1 cervical cancer live longer without the disease coming back. About 510 participants will be randomly assigned to either standard treatment or su…

This early-phase trial tests a new treatment using specially engineered natural killer (NK) cells that target a protein called TROP2 found on cancer cells. The cells are given directly into the abdomen to people with ovarian or pancreatic cancer that has stopped responding to sta…

This study tests whether adding an experimental drug called relacorilant to standard chemotherapy (nab-paclitaxel and gemcitabine) can help people with metastatic pancreatic cancer live longer without their disease getting worse. About 60 adults who have not yet been treated for …

This study tests a powerful mix of treatments for people with advanced liver cancer that cannot be surgically removed. The approach combines tumor destruction (ablation), targeted therapy (lenvatinib), immunotherapy (tislelizumab), and a procedure that blocks the tumor's blood su…

This early-stage study tests a new PET imaging agent, 18F-Clofarabine, to measure an enzyme (DCK) activity in metastatic cancers. The goal is to see if this scan can predict whether drugs like gemcitabine will be taken up by cancer cells. About 4 adults with metastatic cancer wil…

This study is gathering health information from 12,000 adults with lung or other chest cancers. Researchers want to see how factors like genes, lifestyle, and treatments affect outcomes in everyday medical practice. No new treatments are tested—just data collected to help doctors…

This study aims to understand why prostate cancer grows and spreads differently in different people. Researchers will follow 3000 men with prostate cancer from Guadeloupe, Martinique, and Brittany, tracking their genetics, lifestyle, and health over time. The goal is to identify …

This study is creating a large collection of tumor samples and medical information from 1,500 people with pancreatic cancer. The goal is to provide resources for future research, not to test a new treatment. Participants will donate tissue and data during their standard care.